Stephens Consulting’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Sell |
543
-66
| -11% | -$2.53K | ﹤0.01% | 256 |
|
|
2025
Q1 | $23.6K | Buy |
609
+163
| +37% | +$6.32K | 0.01% | 245 |
|
|
2024
Q4 | $15.1K | Buy |
446
+275
| +161% | +$9.3K | ﹤0.01% | 305 |
|
|
2024
Q3 | $6.99K | Hold |
171
| – | – | ﹤0.01% | 366 |
|
|
2024
Q2 | $6.58K | Hold |
171
| – | – | ﹤0.01% | 377 |
|
|
2024
Q1 | $7.33K | Hold |
171
| – | – | ﹤0.01% | 338 |
|
|
2023
Q4 | $6.34K | Hold |
171
| – | – | ﹤0.01% | 356 |
|
|
2023
Q3 | $6.2K | Hold |
171
| – | – | ﹤0.01% | 358 |
|
|
2023
Q2 | $6.1K | Hold |
171
| – | – | ﹤0.01% | 361 |
|
|
2023
Q1 | $6.09K | Hold |
171
| – | – | ﹤0.01% | 374 |
|
|
2022
Q4 | $6.01K | Hold |
171
| – | – | ﹤0.01% | 356 |
|
|
2022
Q3 | $5.03K | Sell |
171
-1
| -0.6% | -$29 | ﹤0.01% | 403 |
|
|
2022
Q2 | $9.36K | Hold |
172
| – | – | 0.01% | 331 |
|
|
2022
Q1 | $9.37K | Hold |
172
| – | – | 0.01% | 360 |
|
|
2021
Q4 | $9.48K | Buy |
+172
| New | +$9.48K | 0.01% | 396 |
|